Share

Remdesivir trial seeing rapid recoveries in early data, according to trial

CNBC's Meg Tirrell reports on the latest data from trials of Gilead's Remdesivir to treat coronavirus.
01:59
Fri, Apr 17 202011:49 AM EDT